Unknown PHASE4 INTERVENTIONAL 2-arm NCT02169843

Small Doses of Dexmedetomidine for Emergence Agitation

Influence of Small Doses Dexmedetomidine to the Elderly Patients' Emergence Agitation

Sponsor: Tang-Du Hospital

Interventions Dexmedetomidine Placebo(for Dexmedetomidine) Sevoflurane

Updated 6 times since 2017 Last updated: Jun 19, 2014 Started: May 31, 2014 Primary completion: Oct 31, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Emergence Agitation and is currently ongoing. Tang-Du Hospital leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tang-Du Hospital

Data source: Tang-Du Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xi’an, China